Article
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.
Cancer immunology, immunotherapy : CII - 1 Jun 2023
Friedhoff Jana, Schneider Felix, Jurcic Christina, Endris Volker, Kirchner Martina, Sun Angela, Bolnavu Iulia, Pohl Laura, Teroerde Miriam, Kippenberger Maximilian, Schwab Constantin, Kaczorowski Adam, Zschäbitz Stefanie, Jäger Dirk, Hohenfellner Markus, Stenzinger Albrecht, Duensing Anette, Duensing Stefan
Abstract excerpt
Clear cell renal cell carcinoma (ccRCC) is an immunologically vulnerable tumor entity, and immune checkpoint inhibitors are now widely used to treat patients with advanced disease. Whether and to what extent immune responses in ccRCC are shaped by genetic alterations, however, is only beginning to emerge. In this proof-of-concept study, we performed a detailed correlative analysis of the mutational and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
